Overview
- Helius Medical Technologies, now operating as Solana Company (Nasdaq: HSDT), disclosed holdings of more than 2.2 million SOL plus over $15 million in cash, citing a $232.50 reference price as of Oct. 6.
- The combined value tops $525 million, which the company notes exceeds the gross proceeds from its private placement that closed on Sept. 18.
- Management said the cash reserves will be used to further expand the digital asset treasury, positioning the company as a long‑term SOL holder with staking to capture native yield.
- Shares rose following the update, with one outlet reporting a 7.7% advance to a $17.49 close as trading volume picked up.
- Executives pointed to growing institutional interest, particularly in Asia, as the company joins other public firms building SOL treasuries, including Forward Industries and DeFi Development Corp.